129 related articles for article (PubMed ID: 37721191)
1. Considerations and Concerns Regarding the Use of Ertapenem in Patients With Hypoalbuminemia: Is It Truly Inappropriate?
Phinder-Puente ME; Pérez-Nieto OR; Mondragón-Labelle TO; Pérez-Barragán E; Soto Muñoz L; Deloya-Tomas E
Clin Infect Dis; 2024 Feb; 78(2):488-489. PubMed ID: 37721191
[No Abstract] [Full Text] [Related]
2. Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study.
Zusman O; Farbman L; Tredler Z; Daitch V; Lador A; Leibovici L; Paul M
Clin Microbiol Infect; 2015 Jan; 21(1):54-8. PubMed ID: 25636928
[TBL] [Abstract][Full Text] [Related]
3. Oral ertapenem for refractory pouchitis.
Ham M; Moss A
J Crohns Colitis; 2013 Nov; 7(10):e501-2. PubMed ID: 23694856
[No Abstract] [Full Text] [Related]
4. Penetration of ertapenem into muscle measured by in vivo microdialysis in mechanically ventilated patients.
Boyadjiev I; Boulamery A; Simon N; Martin C; Bruguerolle B; Leone M
Antimicrob Agents Chemother; 2011 Jul; 55(7):3573-5. PubMed ID: 21576440
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?
dos Santos RP; Jacoby T; Goldani LZ
Antimicrob Agents Chemother; 2010 Jul; 54(7):3076; author reply 3076-7. PubMed ID: 20554969
[No Abstract] [Full Text] [Related]
6. Influence of ertapenem administration on the incidence of carbapenem-resistant Pseudomonas aeruginosa.
Lima AL; Oliveira PR; Paula AP; Zumiotti AV
Braz J Infect Dis; 2008 Apr; 12(2):105-6. PubMed ID: 18641844
[No Abstract] [Full Text] [Related]
7. Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.
Blanchette LM; Kuti JL; Nicolau DP; Nailor MD
Scand J Infect Dis; 2014 Nov; 46(11):803-8. PubMed ID: 25262922
[TBL] [Abstract][Full Text] [Related]
8. Comparative Plasma Pharmacokinetics of Ceftriaxone and Ertapenem in Normoalbuminemia, Hypoalbuminemia, and Albumin Replacement in a Sheep Model.
Dhanani JA; Ahern B; Lupinsky L; Jackson K; Wallis SC; Abdul-Aziz MH; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366707
[TBL] [Abstract][Full Text] [Related]
9. Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.
Nicolau DP; Carmeli Y; Crank CW; Goff DA; Graber CJ; Lima AL; Goldstein EJ
Int J Antimicrob Agents; 2012 Jan; 39(1):11-5. PubMed ID: 22047702
[TBL] [Abstract][Full Text] [Related]
10. [Ertapenem in combined therapy for generalized peritonitis].
Khachatrian NN; Dibirov MD; Poliakov IA; Karsot'ian GS; Fesenko TA
Khirurgiia (Mosk); 2008; (10):64-7. PubMed ID: 19043847
[No Abstract] [Full Text] [Related]
11. Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Collins VL; Marchaim D; Pogue JM; Moshos J; Bheemreddy S; Sunkara B; Shallal A; Chugh N; Eiseler S; Bhargava P; Blunden C; Lephart PR; Memon BI; Hayakawa K; Abreu-Lanfranco O; Chopra T; Munoz-Price LS; Carmeli Y; Kaye KS
Antimicrob Agents Chemother; 2012 Apr; 56(4):2173-7. PubMed ID: 22290982
[TBL] [Abstract][Full Text] [Related]
12. [Adequacy of treatment with ertapenem according to the criterion approved for the infection´s commission of a specialty hospital].
Manzano-García M; Márquez-Saavedra E
Rev Esp Quimioter; 2016 Aug; 29(4):195-201. PubMed ID: 27305510
[TBL] [Abstract][Full Text] [Related]
13. Ertapenem for diabetic foot infections.
Rogers LC; Bevilacqua NJ; Armstrong DG
Drugs Today (Barc); 2006 Nov; 42(11):695-701. PubMed ID: 17171188
[TBL] [Abstract][Full Text] [Related]
14. Ertapenem and all that.
Mani MK
Natl Med J India; 2008; 21(5):256-7. PubMed ID: 19320330
[No Abstract] [Full Text] [Related]
15. [New Beta-lactam agent in the treatment of intra-abdominal sepsis: double blind and randomized stage III study of ertapenem versus piperacillin/tazobactam].
Barboza E; Solomkin J; Goldstein EJ; del Castillo M; Alvarado R; Barboza A; Teppler H
Rev Gastroenterol Peru; 2003; 23(3):192-8. PubMed ID: 14532920
[TBL] [Abstract][Full Text] [Related]
16. Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
Ceccarelli G; Falcone M; Giordano A; Mezzatesta ML; Caio C; Stefani S; Venditti M
Antimicrob Agents Chemother; 2013 Jun; 57(6):2900-1. PubMed ID: 23571536
[No Abstract] [Full Text] [Related]
17. Ertapenem.
Congeni BL
Expert Opin Pharmacother; 2010 Mar; 11(4):669-72. PubMed ID: 20163277
[TBL] [Abstract][Full Text] [Related]
18. Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
Teng CP; Chen HH; Chan J; Lye DC
Int J Antimicrob Agents; 2007 Oct; 30(4):356-9. PubMed ID: 17631986
[TBL] [Abstract][Full Text] [Related]
19. Drug interaction between tacrolimus and ertapenem in renal transplantation recipients.
Bora F; Aliosmanoglu I; Kocak H; Dinckan A; Uslu HB; Gunseren F; Suleymanlar G
Transplant Proc; 2012 Dec; 44(10):3029-32. PubMed ID: 23195020
[TBL] [Abstract][Full Text] [Related]
20. Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
Bai N; Sun C; Wang J; Cai Y; Liang B; Zhang L; Liu Y; Wang R
Chin Med J (Engl); 2014; 127(6):1118-25. PubMed ID: 24622445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
